2m 2m 2m 2m 2m 2m 2m
BEAM THERAPEUTIC (BEAM)
NASDAQ
$31.08+$0.08 (+0.26%)
Price as of Jul 14, 2026 4:17 AM EDT- $3.4BMarket Cap
- 46.43%1-Year Change
- BiotechnologyIndustry
BEAM THERAPEUTIC (BEAM)
$31.08+$0.08 (+0.26%)
BEAM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $31.00 | ||
Change | -$1.68 (-5.14%) | ||
Open | $31.69 | ||
High | $32.19 | ||
Low | $30.78 | ||
Previous Close | $32.68 | ||
Volume | 2,862,285 | ||
30-Day Average Volume | 2,816,778 | ||
1-Week Change | -12.23% | ||
1-Month Change | 6.79% | ||
1-Year Change | 46.43% | ||
3-Year Change | -3.40% | ||
5-Year Change | -65.82% | ||
Fundamentals | |||
Shares Outstanding | 102.9M | ||
Total Assets | $1.5B | ||
Market Cap | $3.4B | ||
Enterprise Value | $3.2B | ||
Period: QTR TTM FY | |||
Revenue | $31.7M | ||
Net Income | -$94.3M | ||
Free Cash Flow | -$130.7M | ||
EBIT | -$93.3M | ||
EBITDA | -$87.7M | ||
Net Working Capital | $1.2B | ||
EPS | -$0.91 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 100 | ||
P/B | 3 | ||
P/E | -36 | ||
PEG | 0 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 02/04/2014 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue